NASDAQ:CRDN

Ceradyne (CRDN) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CRDN stock logo

About Ceradyne Stock (NASDAQ:CRDN)

Ceradyne, Inc. develops, manufactures and markets advanced technical ceramic products, ceramic powders and components for defense, industrial, energy, automotive/diesel and commercial applications. The Company operates through four segments: Advanced Ceramic Operations division, ESK Ceramics subsidiary, Thermo Materials division and Boron segment. The Company’s products include lightweight ceramic armor and enhanced combat helmets for soldiers and other military applications; ceramic industrial components for erosion and corrosion resistant applications; ceramic powders, including boron carbide, boron nitride, titanium diboride, calcium hexaboride, zirconium diboride and fused silica, which are used in manufacturing armor and a range of industrial products and consumer products, and evaporation boats for metallization of materials for food packaging and other products. On January 3, 2011, The Company acquired VIOX Corporation.

CRDN Stock News Headlines

narrative-science
Body Armor Plates Global Market Report 2023
The only AI company you should be looking at
This is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse.
Ceradyne Stock Hits New 52-Week High (CRDN)
Cramer's 'Mad Money' Recap: Misery Loves Usury
Market Preview: All About Apple
The only AI company you should be looking at
This is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse.
The Benefits of Selling Too Soon
See More Headlines
Receive CRDN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ceradyne and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:CRDN
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

This page (NASDAQ:CRDN) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners